Haisong Liu

Title: Haisong Liu: Innovator in Pancreatic Cell Research

Introduction

Haisong Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the identification and selection of pancreatic internal secretion precursor cells. His innovative work has implications for diabetes research and regenerative medicine.

Latest Patents

Haisong Liu holds a patent for the use of SUSD2 protein as a marker. This patent details how the SUSD2 protein can be utilized in the identification, selection, or separation of pancreatic internal secretion precursor cells and newborn pancreatic internal secretion cells. The analysis of gene expression in pancreatic endoderm cells, derived from induced differentiation of human pluripotent stem cells, reveals the enrichment of the SUSD2 gene in these specific cell types. The protein encoded by the SUSD2 gene acts as a receptor on cell membranes, facilitating the identification and separation of these crucial cells.

Career Highlights

Throughout his career, Haisong Liu has worked with esteemed institutions such as Peking University and Beijing Ruipu Chenchuang Technology Co., Ltd. His research has garnered attention for its potential applications in medical science, particularly in understanding pancreatic functions and diseases.

Collaborations

Haisong Liu has collaborated with notable colleagues, including Hongkui Deng and Dicong Zhu. These partnerships have furthered his research and contributed to advancements in the field.

Conclusion

Haisong Liu's innovative work in the use of SUSD2 protein as a marker for pancreatic cells highlights his significant contributions to biotechnology. His research not only enhances our understanding of pancreatic functions but also paves the way for future medical advancements.